---
title: "Tuoxin Pharmaceutical's subsidiary product Glyceryl Phosphoryl Choline has passed the US Self-GRAS certification"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261584359.md"
description: "Tuoxin Pharmaceutical's wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd., has obtained Self-GRAS certification from the U.S. FDA for its product, Glycerophosphocholine. This product is a naturally occurring choline compound that offers several core benefits, including enhancing cognitive function, supporting brain health, improving athletic performance, and providing neuroprotection"
datetime: "2025-10-17T09:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261584359.md)
  - [en](https://longbridge.com/en/news/261584359.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261584359.md)
generator: "portal-rs"
---

# Tuoxin Pharmaceutical's subsidiary product Glyceryl Phosphoryl Choline has passed the US Self-GRAS certification

According to the announcement from Tuoxin Pharmaceutical (301089.SZ), its wholly-owned subsidiary Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as "Jingquan Biotechnology") has completed a rigorous scientific evaluation of its product, Glyceryl Phosphoryl Choline, in accordance with the U.S. Food and Drug Administration (FDA) "Generally Recognized as Safe" (GRAS) guidelines, successfully obtaining Self-GRAS status.

The announcement indicates that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and is also a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operation to maintain brain health, aiding in improved athletic performance and post-exercise recovery, as well as providing neuroprotective effects to ensure the health of the nervous system

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [SP Group corrects disclosure, names Schur Finance as buyer of 31,500 shares at DKK 485](https://longbridge.com/en/news/296803384.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [BMS Holdings Q4 FY2026 PAT Rises 106.5% QoQ to RM5.04 Million](https://longbridge.com/en/news/296892849.md)
- [MediaTek’s rumored Dimensity 9600 Pro appears in benchmark leak](https://longbridge.com/en/news/296869710.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**